During large-scale sequencing to identify mutations in protein kinases in human cancer cells and primary tissue, we identified a heterozygous missense mutation in the cdk2 gene in a short-term culture of a glioblastoma (data not shown). This evidence concerns the gene CDK2 and glioblastoma.